Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,020,909
-
Total 13F shares
-
46,958,559
-
Share change
-
+90,009
-
Total reported value
-
$7,173,472,632
-
Put/Call ratio
-
26%
-
Price per share
-
$152.76
-
Number of holders
-
403
-
Value change
-
+$23,088,239
-
Number of buys
-
192
-
Number of sells
-
169
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) as of Q4 2019
As of 31 Dec 2019,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) was held by
403 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,958,559 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, AQR CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, STATE STREET CORP, BROWN ADVISORY INC, and FIL Ltd.
This page lists
403
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.